A bill would allow Ohio state employees to purchase GLP-1s from manufacturers, then would require the Department of ...

A US study by the Centers for Disease Control reveals the drug hospitalises nearly 70 people daily in America. CEO of Calocurb, a natural appetite suppressant company, Sarah Kennedy, says this is ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Access is opening up for Kiwis to a weight loss drug described as a game changer. Wegovy, made by pharma-co Novo Nordisk, ...

A new bill could make the price of one prescription drug cheaper for state employees. The bill would eliminate pharmacy benefit managers, or PBM, usage when it comes to coverage for GLP-1s. Those ...

A new bill could make the price of prescription drugs known for weight loss cheaper for the state to buy for its employees.

With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

Of the 102,166 GLP-1s analyzed, 94% had some form of commercial insurance, yet cost-saving options were still widely overlooked.

Shares in biopharmaceutical company Viking Therapeutics (NASDAQ: VKTX) were up by 6.3% at 12:30 a.m. ET today. The move ...

A separate Prime analysis, however, of year-over-year claims data for Wegovy and Zepbound only found an improvement in ...

Altimmune, Inc.'s Pemvidutide shows promise in MASH treatment with liver improvements and safety, despite market overreaction. Click for my ALT stock update.